Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01098929 |
Recruitment Status
: Unknown
Verified December 2015 by Patricia Donahoe, MD, Massachusetts General Hospital.
Recruitment status was: Recruiting
First Posted
: April 5, 2010
Last Update Posted
: December 17, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Congenital Diaphragmatic Hernia |
This study uses a combination of clinical, molecular biological, and developmental strategies to better understand the genetic basis of congenital diaphragmatic hernia. Ongoing projects at Massachusetts General Hospital include identification of novel genes affecting diaphragm and lung development in a) mouse models using laser capture, microdissection, expression arrays, and statistical and bioinformatics analysis and b) human kindreds with multiple affected family members using linkage analysis and exome sequencing.
Research projects based at Children's Hospital Boston include a) continued recruitment of a population of patients with congenital diaphragmatic hernia who are carefully phenotyped for entry into an extensive database, b) collection of biological samples belonging to the phenotyped cohort of patients, c) next-generation sequencing on candidate genes and d) molecular cytogenetic studies such as comparative genomic hybridization and subtelomeric fluorescence in situ hybridization.
Over 500 patients with congenital diaphragmatic hernia and their families have been recruited to date and efforts are ongoing to double this number. The investigators hope that the information gained through identifying the genes that contribute to congenital diaphragmatic hernia will provide the foundation for future efforts to develop effective interventions for the treatment of this disease.
Study Type : | Observational |
Estimated Enrollment : | 1000 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia |
Study Start Date : | July 2002 |
Estimated Primary Completion Date : | July 2017 |
Estimated Study Completion Date : | July 2017 |

Group/Cohort |
---|
Congenital Diaphragmatic Hernia (CDH)
Individuals affected with congenital diaphragmatic hernia (CDH)
|
Unaffected
Healthy family members of individuals affected with congenital diaphragmatic hernia (CDH)
|
- identify genes associated with CDH [ Time Frame: 5 years ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Children/infants with a congenital diaphragmatic hernia
Women who are currently pregnant with a fetus diagnosed with congenital diaphragmatic hernia
Individuals with a family history of congenital diaphragmatic hernia
Inclusion Criteria:
All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of CDH
Exclusion Criteria:
Individuals with no personal or family history of a CDH

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01098929
Contact: Jessica Kim, BS | 617-355-2555 | jessica.kim2@childrens.harvard.edu |
United States, Massachusetts | |
Children's Hospital Boston | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Jessica Kim, BS 617-355-2555 jessica.kim2@childrens.harvard.edu | |
Principal Investigator: Jay Wilson, MD |
Principal Investigator: | Patricia Donahoe, MD | Massachusetts General Hospital | |
Principal Investigator: | Jay Wilson, MD | Boston Children’s Hospital |
Responsible Party: | Patricia Donahoe, MD, Principal Investigator and Program Director, Pediatric Surgical Research Laboratories, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT01098929 History of Changes |
Other Study ID Numbers: |
05-07-105R |
First Posted: | April 5, 2010 Key Record Dates |
Last Update Posted: | December 17, 2015 |
Last Verified: | December 2015 |
Keywords provided by Patricia Donahoe, MD, Massachusetts General Hospital:
genes genetic chromosome chromosome microarray |
Additional relevant MeSH terms:
Hernia Hernia, Diaphragmatic Hernias, Diaphragmatic, Congenital Pathological Conditions, Anatomical Congenital Abnormalities |